Aclaris Therapeutics Set for Exciting November Healthcare Events

Author: Logan Wright Updated: 10-29-2025 07:47 AM

Aclaris Therapeutics' Upcoming Healthcare Conferences in November

WAYNE, Pa. — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company specializing in immuno-inflammatory diseases, has exciting plans for November. The company is set to participate in three significant healthcare conferences that promise to showcase its cutting-edge developments and strategies.

First Event: Guggenheim's 2nd Annual Healthcare Conference

On November 12, Aclaris’ Chief Executive Officer, Dr. Neal Walker, along with other senior leaders, will engage in a fireside chat at the Guggenheim 2nd Annual Healthcare Conference. This event, held in Boston, is a great opportunity for Aclaris to share insights about their innovative pipeline and discuss the company’s vision for the future.

Second Event: Stifel 2025 Healthcare Conference

Also on November 12, Dr. Hugh Davis, the President and Chief Operating Officer of Aclaris, will lead another fireside chat during the Stifel 2025 Healthcare Conference. This event will take place in New York, allowing Aclaris to connect with investors and healthcare professionals to present their groundbreaking strategies and achievements.

Final Event: Jefferies Global Healthcare Conference

On November 17, Dr. Walker will represent Aclaris at the Jefferies Global Healthcare Conference in London. This will mark an important occasion for the company, providing a platform to discuss their advancements and collaborations in tackling immuno-inflammatory diseases.

Access to Webcasts

For those unable to attend in person, Aclaris will provide live and archived webcasts of each event. Interested individuals can access these webcasts through the company's website, ensuring that stakeholders and enthusiasts stay updated on the latest developments.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics is focused on developing a wide array of innovative product candidates tailored for patients suffering from immuno-inflammatory conditions. With a robust research and development framework, Aclaris is dedicated to addressing therapeutic gaps and enhancing patient care with their evolving portfolio of treatments. For more information regarding their ongoing projects, visit their official website and stay informed via social media platforms.

Contact Information

For inquiries, you can reach Aclaris Therapeutics through:
Will Roberts
Senior Vice President, Corporate Communications and Investor Relations
(484) 329-2125
Email: wroberts@aclaristx.com

Frequently Asked Questions

What is Aclaris Therapeutics focused on?

Aclaris is focused on developing novel product candidates for immuno-inflammatory diseases.

When are the key conferences for Aclaris in November?

The conferences are on November 12 and November 17.

Who will represent Aclaris at the events?

Dr. Neal Walker and Dr. Hugh Davis will participate in discussions at the events.

Will the conferences be available for viewing later?

Yes, live and archived webcasts will be accessible through the company's website.

How can I contact Aclaris Therapeutics?

You can contact Aclaris through Will Roberts, Senior VP of Corporate Communications, via email.

About The Author

Dedicated Author and financial expert Logan Wright here, 29 years old. After earning an economics degree, I spent a number of years working in different financial industries. My great passion is enabling everyone, from any background or experience level, to understand and be literate in financial matters.

My books and writings are centered on simplifying difficult financial ideas into doable, understandable guidance. Whether it's retirement planning, investing, or budgeting, I want to arm readers with the information they need to make wise financial choices and realize their financial objectives.

Apart from writing, I also frequently post to financial blogs and organize webinars and workshops targeted at enlightening participants about personal finance. Always, my strategy is to offer concise, doable advice that can truly improve people's lives.

Away from work, I like to read, travel, and sample new foods. My goal is to infuse everything I do with the balance that I think is essential to both financial and personal well-being. By my profession, I want to encourage and enable people to confidently and clearly take charge of their financial futures.

Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.